Bipolar Funding Consortium Aims to Unravel Disorder's Genetics, Reduce Healthcare Disparities
Premium
The ambitious set of projects aims to improve our understanding of bipolar disorder and inform care across the entire spectrum of research and clinical practice.
New data has demonstrated that DNA fragment size differences that discriminate preeclampsia from healthy controls can be detected using a lower-cost PCR method.
Harbinger Health Raises $140 Million in Series B Financing
The firm said the funds will enable completion of clinical validation of its first blood-based cancer screening product ahead of an anticipated 2025 launch.
Ginkgo Bioworks, Pfizer Ink RNA Drug Discovery Deal Worth up to $331M
The deal is the latest multimillion-dollar collaboration to come out of Ginkgo Bioworks' concerted effort to court the pharmaceutical industry in 2023.
Genetic Overlap Between Schizophrenia, Cardiovascular Disease Risk Uncovered by GWAS Analysis
Scientists found an overlap in genetic variants between schizophrenia and CVD risk factors by analyzing the results of multiple GWAS of people of European descent.
Adela Closes $48M Financing to Develop Cancer Monitoring, Early Detection Test
The company will use the proceeds to advance its technology platform and commercialize its first product for minimal residual disease monitoring.